Savient Pharm (SVNT) - Description of business
Watch the video to learn about the probability of Savient Pharm (SVNT) Chart Signal as of May 18 2013
Hotstocked Precision will calculate the probabilities of Savient Pharm (SVNT)
Also, in January 2006 we completed the sale to Indevus Pharmaceuticals, Inc. (“Indevus”) of Delatestryl, our former injectable testosterone product for male hypogonadism. Under the terms of the sale, Indevus paid us an initial payment of $5 million and a portion of net sales of the product for the first three years following closing of the transaction based on an escalating scale.